Propanc Biopharma Stock Cash And Equivalents
Propanc Biopharma fundamentals help investors to digest information that contributes to Propanc Biopharma's financial success or failures. It also enables traders to predict the movement of Propanc Pink Sheet. The fundamental analysis module provides a way to measure Propanc Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Propanc Biopharma pink sheet.
Propanc |
Propanc Biopharma Company Cash And Equivalents Analysis
Propanc Biopharma's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Propanc Biopharma Cash And Equivalents | 51.22 K |
Most of Propanc Biopharma's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Propanc Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Propanc Biopharma has 51.22 K in Cash And Equivalents. This is 99.99% lower than that of the Healthcare sector and 99.99% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
Propanc Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Propanc Biopharma's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Propanc Biopharma could also be used in its relative valuation, which is a method of valuing Propanc Biopharma by comparing valuation metrics of similar companies.Propanc Biopharma is currently under evaluation in cash and equivalents category among its peers.
Propanc Fundamentals
| Current Valuation | 1.32 M | |||
| Shares Outstanding | 691.17 K | |||
| Shares Owned By Insiders | 1.94 % | |||
| Shares Owned By Institutions | 1.94 % | |||
| EBITDA | (2.97 M) | |||
| Net Income | (3.67 M) | |||
| Cash And Equivalents | 51.22 K | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 1.1 M | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (4.44) X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | (16.63) X | |||
| Beta | 2.05 | |||
| Market Capitalization | 259.19 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Propanc Pink Sheet
If you are still planning to invest in Propanc Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Propanc Biopharma's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |